Hereditary 1,25-dihydroxyvitamin D resistant rickets: Molecular basis and implications for the role of 1,25(OH)2D3 in normal physiology

This publication has 44 references indexed in Scilit:

• Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1α,25-dihydroxyvitamin D3 receptor
  Molecular and Cellular Endocrinology, 1990
• The Role of the Vitamin D Endocrine System in Health and Disease
  New England Journal of Medicine, 1989
• A splicing defect due to an exon-intron junctional mutation results in abnormal β-hexosaminidase α chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease
  Biochemical and Biophysical Research Communications, 1988
• Myeloid progenitors from the bone marrow of patients with vitamin D resistant rickets (type II) fail to respond to 1,25(OH)₂D₃
  British Journal of Haematology, 1987
• Rapid diagnosis of vitamin D-dependent rickets type II by use of phytohemagglutinin-stimulated lymphocytes
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1986
• Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.
  Journal of Clinical Investigation, 1985
• VITAMIN D RESISTANT RICKETS WITH ALOPECIA: A FORM OF END ORGAN RESISTANCE TO 1,25 DIHYDROXY VITAMIN D
  Clinical Endocrinology, 1981
• END-ORGAN RESISTANCE TO 1,25-DIHYDROXYCHOLECALCIFEROL
  The Lancet, 1980
• Rickets with alopecia: An inborn error of vitaminD metabolism
  The Journal of Pediatrics, 1979
• Vitamin-D-Dependent Rickets Type II
  New England Journal of Medicine, 1978